PT Merck Tbk
Indonesia Stock ExchangeTotal Valuation
PT Merck Tbk carries a market capitalization of 1.65T, placing it among publicly traded companies globally. Its enterprise value stands at 950.84B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.65T |
| Enterprise Value | 950.84B |
Share Statistics
PT Merck Tbk currently has 448.00M shares outstanding.
| Shares Outstanding | 448.00M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
PT Merck Tbk trades at a trailing price-to-earnings ratio of 4.65. The price-to-sales ratio is 1.08, and the price-to-book ratio stands at 1.35.
| PE Ratio | 4.65 |
| PS Ratio | 1.08 |
| PB Ratio | 1.35 |
| P/TBV Ratio | 1.32 |
| P/FCF Ratio | 68.71 |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, PT Merck Tbk trades at an EV/EBITDA multiple of 2.48 and an EV/FCF ratio of 44.59. The EV/Sales ratio of 0.75 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 2.48 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.75 |
| EV / EBITDA | 2.48 |
| EV / EBIT | 2.48 |
| EV / FCF | 44.59 |
Financial Position
PT Merck Tbk maintains a current ratio of 4.91, meaning it holds 4.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 1.79, indicating elevated leverage, while an interest coverage ratio of 221.14 demonstrates strong ability to service its debt obligations.
| Current Ratio | 4.91 |
| Quick Ratio | 1.98 |
| Debt / Equity | 1.79 |
| Debt / EBITDA | 0.05 |
| Interest Coverage | 221.14 |
Financial Efficiency
PT Merck Tbk posts a return on equity of 32.56 and a return on invested capital of 28.71.
| Return on Equity (ROE) | 32.56 |
| Return on Assets (ROA) | 25.65 |
| Return on Invested Capital (ROIC) | 28.71 |
| Return on Capital Employed (ROCE) | 32.06 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.00 |
Taxes
Over the trailing twelve months, PT Merck Tbk has paid 97.87B in income taxes, reflecting an effective tax rate of 24.86.
| Income Tax | 97.87B |
| Effective Tax Rate | 24.86 |
Stock Price Statistics
PT Merck Tbk's stock has gained approximately 24.66216% over the past 52 weeks. The 50-day moving average sits at 3,880.80, while the 200-day moving average is 3,328.05.
| Beta (5Y) | N/A |
| 52-Week Price Change | 24.66216% |
| 50-Day Moving Average | 3,880.80 |
| 200-Day Moving Average | 3,328.05 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, PT Merck Tbk generated 1.27T in revenue and converted that into 295.88B in net income, yielding earnings per share of 660.45. EBITDA reached 384.15B, while operating income came in at 384.15B.
| Revenue | 1.27T |
| Gross Profit | 621.85B |
| Operating Income | 384.15B |
| Pretax Income | 393.75B |
| Net Income | 295.88B |
| EBITDA | 384.15B |
| EBIT | 384.15B |
| Earnings Per Share (EPS) | 660.45 |
Balance Sheet
PT Merck Tbk holds 443.14B in cash and equivalents against 18.62B in total debt, resulting in a net debt position of -443.14B. Total book value stands at 1.02T, with working capital of 875.16B providing operational flexibility.
| Cash & Cash Equivalents | 443.14B |
| Total Debt | 18.62B |
| Net Debt | -443.14B |
| Equity (Book Value) | 1.02T |
| Book Value Per Share | 2,274.22 |
| Working Capital | 875.16B |
Cash Flow
After subtracting -20.02B in capital expenditures, free cash flow totaled -20.02B - equivalent to -44.68 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -20.02B |
| Free Cash Flow | -20.02B |
| FCF Per Share | -44.68 |
Margins
PT Merck Tbk operates with a gross margin of 49.02, reflecting its pricing power and cost economics. The operating margin of 30.28 and net profit margin of 23.32 provide insight into operational efficiency.
| Gross Margin | 49.02 |
| Operating Margin | 30.28 |
| Pretax Margin | 31.04 |
| Profit Margin | 23.32 |
| EBITDA Margin | 30.28 |
Dividends & Yields
The company's payout ratio of 25.62 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 169.19 |
| Dividend Yield | N/A |
| Payout Ratio | 25.62 |
| Shareholder Yield | 6.08 |
| FCF Yield | 1.46 |
Stock Splits
PT Merck Tbk's most recent stock split took place on December 21, 2015 with a 1:20 split ratio.
| Last Split Date | 12/21/2015 |
| Split Ratio | 1:20 |
Scores
PT Merck Tbk posts an Altman Z-Score of 6.68, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 6.68 |